Vitamin-based cancer therapy: Epigallocatechin gallate, the major component of Green tea, inhibits cancer development by suppressing the expression of nucleotide sanitizing enzyme MTH1/NUDT1, 19/April/2014, 11.23 am

Insights into regulatory mechanisms that control Scar healing: MiRNA Let-7 suppresses the expression of human telomerase reverse transcriptase via down regulation of its target gene, 19/May/2014, 11.10 am
May 19, 2014
Insights into Lifespan regulation: Prolonged Stress-induced activation of the tumor suppressor p53 suppresses the longevity of an organism via up regulation of its target gene, 20/May/2014, 6.04 am
May 20, 2014
Show all

A study from Karolinska Institutet, Stockholm, Sweden shows that MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. 

This study was published in the April 10, 2014 Nature by Prof. Dr Thomas H, Dr Gad H and others from Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Vitamin-based cancer therapy: Epigallocatechin gallate, the major component of Green tea, inhibits cancer development by suppressing the expression of nucleotide sanitizing enzyme MTH1/NUDT1

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Vitamin-based cancer therapy: Epigallocatechin gallate, the major component of Green tea, inhibits cancer development by suppressing the expression of nucleotide sanitizing enzyme MTH1/NUDT1, 19/April/2014, 11.23 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.